Intrafamilial aggregation of gastric cancer: A comprehensive approach including environmental factors, Helicobacter pylori virulence, and genetic susceptibility

European Journal of Gastroenterology and Hepatology

Volumn 23, Issue 5, 2011, Pages 411-417

  Shin, Cheol Min ^a   Kim, Nayoung ^a,b   Lee, Hye Seung ^a   Lee, Dong Ho ^a,b   Kim, Joo Sung ^b   Jung, Hyun Chae ^b   Song, In Sung ^b  

^a Seoul National University Bundang Hospital   (South Korea)

^b Seoul National University College of Medicine   (South Korea)

Author keywords

Environmental factors; gastric cancer; genetic susceptibility; Helicobacter pylori; relative

Indexed keywords

BACTERIAL PROTEIN; CAGA PROTEIN; OIPA PROTEIN; PROTEIN M1; S1 PROTEIN; UNCLASSIFIED DRUG; VAGA PROTEIN; VIRULENCE FACTOR;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CARCINOGENESIS; CONTROLLED STUDY; DEMOGRAPHY; ENVIRONMENTAL FACTOR; FAMILIAL CANCER; FAMILY HISTORY; FEMALE; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; HELICOBACTER PYLORI; HUMAN; INTESTINE METAPLASIA; KOREA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RURAL AREA; SEX RATIO; SMOKING; SOCIAL STATUS; STOMACH CANCER;

ADENOCARCINOMA; ADULT; CLUSTER ANALYSIS; CYTOKINES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; METAPLASIA; MIDDLE AGED; POLYMORPHISM, GENETIC; PREVALENCE; SMOKING; STOMACH NEOPLASMS; VIRULENCE; VIRULENCE FACTORS;

EID: 79955059993     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/MEG.0b013e328343b7f5     Document Type: Article

References (48)

1. Forman D, Burley VJ. Gastric cancer: global pattern of the disease and an overview of environmental risk factors. Best Pract Res Clin Gastroenterol 2006; 20:633-649. (Pubitemid 44391336)
2. WonYJ, Sung J, Jung KW, KongHJ, Park S, ShinHR, et al. Nationwide Cancer Incidence in Korea, 2003-2005. Cancer Res Treat 2009; 41:122-131.
3. Ladeiras-Lopes R, Pereira AK, Nogueira A, Pinheiro-Torres T, Pinto I, Santos-Pereira R, et al. Smoking and gastric cancer: systematic review and meta-analysis of cohort studies. Cancer Causes Control 2008; 19:689-701.
4. Joossens JV, Hill MJ, Elliott P, Stamler R, Lesaffre E, Dyer A, et al. Dietary salt, nitrate and stomach cancer mortality in 24 countries: European Cancer Prevention (ECP) and the INTERSALT Cooperative Research Group. Int J Epidemiol 1996; 25:494-504.
5. Foschi R, Lucenteforte E, Bosetti C, Bertuccio P, Tavani A, La Vecchia C, et al. Family history of cancer and stomach cancer risk. Int J Cancer 2008; 123:1429-1432.
6. Fujimoto Y, Furusyo N, Toyoda K, Takeoka H, Sawayama Y, Hayashi J. Intrafamilial transmission of Helicobacter pylori among the population of endemic areas in Japan. Helicobacter 2007; 12:170-176.
7. Palli D, Galli M, Caporaso NE, Cipriani F, Decarli A, Saieva C, et al. Family history and risk of stomach cancer in Italy. Cancer Epidemiol Biomarkers Prev 1994; 3:15-18. (Pubitemid 24172516)
8. Shin CM, Kim N, Yang HJ, Cho SI, Lee HS, Kim JS, et al. Stomach cancer risk in gastric cancer relatives: interaction between Helicobacter pylori infection and family history of gastric cancer for the risk of stomach cancer. J Clin Gastroenterol 2010; 44:e34-e39.
9. Canedo P, Figueiredo C, Machado JC. After Helicobacter pylori, genetic susceptibility to gastric carcinoma revisited. Helicobacter 2007; 12 (Suppl 2): 45-49. (Pubitemid 350089820)
10. Dixon MF, Genta RM, Yardley JH, Correa P. Classification and grading of gastritis: the updated Sydney system. International Workshop on the Histopathology of Gastritis, Houston 1994. Am J Surg Pathol 1996; 20:1161-1181.
11. Yamaoka Y, Kwon DH, Graham DY. A M(r) 34 000 proinflammatory outer membrane protein (oipA) of Helicobacter pylori. Proc Natl Acad Sci U S A 2000; 97:7533-7538. (Pubitemid 30431498)
12. Yamaoka Y, Kodama T, Gutierrez O, Kim JG, Kashima K, Graham DY. Relationship between Helicobacter pylori iceA, cagA, and vacA status and clinical outcome: studies in four different countries. J Clin Microbiol 1999; 37:2274-2279. (Pubitemid 29277791)
13. Kato S, Onda M, Yamada S, Matsuda N, Tokunaga A, Matsukura N. Association of the interleukin-1 beta genetic polymorphism and gastric cancer risk in Japanese. J Gastroenterol 2001; 36:696-699. (Pubitemid 33040943)
14. Galbraith GM, Pandey JP. Tumor necrosis factor alpha (TNF-alpha) gene polymorphism in alopecia areata. Hum Genet 1995; 96:433-436.
15. Rad R, Dossumbekova A, Neu B, Lang R, Bauer S, Saur D, et al. Cytokine gene polymorphisms influence mucosal cytokine expression, gastric inflammation, and host specific colonisation during Helicobacter pylori infection. Gut 2004; 53:1082-1089. (Pubitemid 38961959)
16. Zhang DL, Zheng HM, Yu BJ, Jiang ZW, Li JS. Association of polymorphisms of IL and CD14 genes with acute severe pancreatitis and septic shock. World J Gastroenterol 2005; 11:4409-4413.
17. Ohyauchi M, Imatani A, Yonechi M, Asano N, Miura A, Iijima K, et al. The polymorphism interleukin 8 -251 A/T influences the susceptibility of Helicobacter pylori related gastric diseases in the Japanese population. Gut 2005; 54:330-335. (Pubitemid 40299086)
18. Hwang IR, Hsu PI, Peterson LE, Gutierrez O, Kim JG, Graham DY, et al. Interleukin-6 genetic polymorphisms are not related to Helicobacter pyloriassociated gastroduodenal diseases. Helicobacter 2003; 8:142-148. (Pubitemid 36522918)
19. Mansfield JC, Holden H, Tarlow JK, Di Giovine FS, McDowell TL,Wilson AG, et al. Novel genetic association between ulcerative colitis and the anti-inflammatory cytokine interleukin-1 receptor antagonist. Gastroenterology 1994; 106:637-642.
20. Brenner H, Bode G, Boeing H. Helicobacter pylori infection among offspring of patients with stomach cancer. Gastroenterology 2000; 118:31-35. (Pubitemid 30020370)
21. El-Omar EM, Oien K, Murray LS, El-Nujumi A, Wirz A, Gillen D, et al. Increased prevalence of precancerous changes in relatives of gastric cancer patients: critical role of H. pylori. Gastroenterology 2000; 118:22-30. (Pubitemid 30020369)
22. Chang YW, Han YS, Lee DK, Kim HJ, Lim HS, Moon JS, et al. Role of Helicobacter pylori infection among offspring or siblings of gastric cancer patients. Int J Cancer 2002; 101:469-474.
23. Sheu BS, Yang HB, Sheu SM, Huang AH, Wu JJ. Higher gastric cycloxygenase-2 expression and precancerous change in Helicobacter pylori-infected relatives of gastric cancer patients. Clin Cancer Res 2003; 9:5245-5251.
24. Soltermann A, Koetzer S, Eigenmann F, Komminoth P. Correlation of Helicobacter pylori virulence genotypes vacA and cagA with histological parameters of gastritis and patient's age. Mod Pathol 2007; 20:878-883. (Pubitemid 47077272)
25. Leung WK, Chan MCW, To K-F, Man EPS, Ng EKW, Chu ESH, et al. H. pylori genotypes and cytokine gene polymorphisms influence the development of gastric intestinal metaplasia in a Chinese population. Am J Gastroenterol 2006; 101:714-720.
26. Umit H, Tezel A, Bukavaz S, Unsal G, Otkun M, Soylu A, et al. The relationship between virulence factors of Helicobacter pylori and severity of gastritis in infected patients. Dig Dis Sci 2009; 54:103-110.
27. Mattar R, dos Santos AF, Eisig J, Rodrigues T, Silva F, Lupinacci R, et al. No correlation of babA2 with vacA and cagA genotypes of Helicobacter pylori and grading of gastritis from peptic ulcer disease patients in Brazil. Helicobacter 2005; 10:601-608. (Pubitemid 41668345)
28. Smith GD, Hart C, Blane D, Hole D. Adverse socioeconomic conditions in childhood and cause specific adult mortality: prospective observational study. BMJ 1998; 316:1631-1635. (Pubitemid 28247990)
29. Malaty HM, Graham DY. Importance of childhood socioeconomic status on the current prevalence of Helicobacter pylori infection. Gut 1994; 35:742-745. (Pubitemid 24193212)
30. Kim N, Kim JG, Kim JH, Kim HY, Kim SW. Risk factors of Helicobacter pylori infection in asymptomatic Korean population. Korean J Med 2000; 59:376-387.
31. Kusters JG, Van Vliet AH, Kuipers EJ. Pathogenesis of Helicobacter pylori infection. Clin Microbiol Rev 2006; 19:449-490. (Pubitemid 44134306)
32. Kang J, Kim N, Lee D, Park J, Lee M, Kim J, et al. The effects of genetic polymorphisms of IL-6, IL-8, and IL-10 on Helicobacter pylori-induced gastroduodenal diseases in Korea. J Clin Gastroenterol 2009; 43:420-428.
33. Jin G,Wang L, Chen W, Hu Z, Zhou Y, Tan Y, et al. Variant alleles of TGFB1 and TGFBR2 are associated with a decreased risk of gastric cancer in a Chinese population. Int J Cancer 2007; 120:1330-1335.
34. El-Omar EM, Carrington M, Chow WH, McColl KE, Bream JH, Young HA, et al. Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature 2000; 404:398-402. (Pubitemid 30164342)
35. Derynck R, Akhurst RJ, Balmain A. TGF-beta signaling in tumor suppression and cancer progression. Nat Genet 2001; 29:117-129. (Pubitemid 32952643)
36. Massague J, Blain SW, Lo RS. TGFbeta signaling in growth control, cancer, and heritable disorders. Cell 2000; 103:295-309.
37. De Caestecker MP, Piek E, Roberts AB. Role of transforming growth factorbeta signaling in cancer. J Natl Cancer Inst 2000; 92:1388-1402.
38. Grainger DJ, Heathcote K, Chiano M, Snieder H, Kemp PR, Metcalfe JC, et al. Genetic control of the circulating concentration of transforming growth factor type beta1. Hum Mol Genet 1999; 8:93-97. (Pubitemid 29039053)
39. Niu W, Qi Y, Gao P, Zhu D. Association of TGFB1-509 C/T polymorphism with breast cancer: evidence from a meta-analysis involving 23 579 subjects. Breast Cancer Res Treat 2010; 124:243-249.
40. Fang F, Yu L, Zhong Y, Yao L. TGFB1 509 C/T polymorphism and colorectal cancer risk: a meta-analysis. Med Oncol 2010; 27:1324-1328.
41. Garcia-Gonzalez MA, Strunk M, Piazuelo E, Benito R, Santolaria S, Jimenez P, et al. TGFB1 gene polymorphisms: their relevance in the susceptibility to Helicobacter pylori-related diseases. Genes Immun 2006; 7:640-646. (Pubitemid 46242368)
42. Ebert MP, Yu J, Miehlke S, Fei G, Lendeckel U, Ridwelski K, et al. Expression of transforming growth factor beta-1 in gastric cancer and in the gastric mucosa of first-degree relatives of patients with gastric cancer. Br J Cancer 2000; 82:1795-1800. (Pubitemid 30307391)
43. Lauren P. The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. An attempt at a histo-clinical classification. Acta Pathol Microbiol Scand 1965; 64:31-49.
44. Bernini M, Barbi S, Roviello F, Scarpa A, Moore P, Pedrazzani C, et al. Family history of gastric cancer: a correlation between epidemiologic findings and clinical data. Gastric Cancer 2006; 9:9-13.
45. Zhou XF, He YL, Song W, Peng JJ, Zhang CH, Li W, et al. Comparison of patients by family history with gastric and non-gastric cancer. World J Gastroenterol 2009; 15:2644-2650.
46. Dunbier A, Guilford P. Hereditary diffuse gastric cancer. Adv Cancer Res 2001; 83:55-65. (Pubitemid 32959261)
47. Carneiro F, Oliveira C, Suriano G, Seruca R. Molecular pathology of familial gastric cancer, with an emphasis on hereditary diffuse gastric cancer. J Clin Pathol 2008; 61:25-30. (Pubitemid 351158221)
48. Kim IJ, Park JH, Kang HC, Shin Y, Lim SB, Ku JL, et al. A novel germline mutation in the MET extracellular domain in a Korean patient with the diffuse type of familial gastric cancer. J Med Genet 2003; 40:e97.